In Proposed Rulemaking, DEA Looks to Expand Mobile Narcotic Treatment Options

Published date28 February 2020
Law FirmFaegre Drinker Biddle & Reath LLP
Subject MatterControlled Substances Act,DEA,Controlled Substances,Health Care Providers
AuthorMatthew Rubin

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT